Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Axenfeld anomaly is an autosomal dominant anterior segment dysgenesis characterized by posterior embryotoxon, iris strands, and elevated risk of glaucoma and vision loss. FOXC1 (HGNC:3800) variants have been repeatedly implicated in this condition. Two pedigrees demonstrated heterozygous FOXC1 mutations segregating fully with disease: a novel wing region missense variant in an Indian family (3 probands)[PMID:12454026] and c.272T>C (p.Ile91Thr) in a four-generation kindred (10 affected)[PMID:15477465].
Genetic evidence supports haploinsufficiency as the mechanism. A total of 13 probands (3[PMID:12454026]; 10[PMID:15477465]) with autosomal dominant inheritance and family segregation meet criteria for a definitive gene–disease relationship, with variant spectrum including missense substitutions within the forkhead domain, frameshift mutations, and gene dosage alterations[PMID:9620769]. One representative pathogenic variant is c.272T>C (p.Ile91Thr).
Functional assays in cultured cells (DNA-binding and transactivation) demonstrated that disease-associated FOXC1 mutations reduce forkhead domain activity[PMID:11179011]. Additionally, zebrafish foxc1a/b knockout models recapitulate anterior segment defects and glaucoma phenotypes, reinforcing haploinsufficiency as the pathogenic mechanism[PMID:32720677].
Although some rare FOXC1 variants have been identified in broad developmental eye anomaly cohorts without clear pathogenicity, bona fide pathogenic alleles cluster in the conserved forkhead region and consistently show deleterious functional effects. No studies have refuted the FOXC1–Axenfeld anomaly association.
In summary, FOXC1 haploinsufficiency is a definitive cause of autosomal dominant Axenfeld anomaly. Clinical genetic testing for FOXC1 variants is indicated in patients with anterior segment dysgenesis, enabling accurate diagnosis, prognosis, and management.
Key Take-home: FOXC1 sequencing should be included in diagnostic workflows for Axenfeld anomaly to guide clinical management.
Gene–Disease AssociationDefinitive13 probands (3[PMID:12454026]; 10[PMID:15477465]) with segregation and concordant functional data Genetic EvidenceStrongAutosomal dominant segregation in two families; diverse variant types including missense and frameshift[PMID:9620769] Functional EvidenceStrongCell-based DNA-binding/transactivation assays and zebrafish knockout models confirm haploinsufficiency[PMID:11179011; PMID:32720677] |